U.S. lawmakers push Mylan, Teva over drug pricing probe: statement

The head of the U.S. House of Representative's oversight panel on Wednesday called on three drugmakers to turn over documents as part of an ongoing congressional review over generic drug price increases and accused the companies of "apparent efforts to stonewall" the probe.

from Reuters: Health News https://ift.tt/2TtPPVU
via IFTTT